KR930700102A - 벤조산 유도체 - Google Patents

벤조산 유도체

Info

Publication number
KR930700102A
KR930700102A KR1019920703091A KR920703091A KR930700102A KR 930700102 A KR930700102 A KR 930700102A KR 1019920703091 A KR1019920703091 A KR 1019920703091A KR 920703091 A KR920703091 A KR 920703091A KR 930700102 A KR930700102 A KR 930700102A
Authority
KR
South Korea
Prior art keywords
compound
aliphatic
pharmaceutically acceptable
carboxyethenyl
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019920703091A
Other languages
English (en)
Korean (ko)
Inventor
에이. 데인스 로버트
데니스 킹스버리 윌리암
Original Assignee
원본미기재
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 스미스클라인 비참 코포레이션 filed Critical 원본미기재
Publication of KR930700102A publication Critical patent/KR930700102A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019920703091A 1990-06-07 1991-05-31 벤조산 유도체 Abandoned KR930700102A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53439790A 1990-06-07 1990-06-07
US534,397 1990-06-07
PCT/US1991/003772 WO1991018601A1 (en) 1990-06-07 1991-05-31 Benzoic acid derivatives

Publications (1)

Publication Number Publication Date
KR930700102A true KR930700102A (ko) 1993-03-13

Family

ID=24129867

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920703091A Abandoned KR930700102A (ko) 1990-06-07 1991-05-31 벤조산 유도체

Country Status (17)

Country Link
EP (1) EP0593464A1 (OSRAM)
JP (1) JPH07116150B2 (OSRAM)
KR (1) KR930700102A (OSRAM)
CN (1) CN1058015A (OSRAM)
AU (1) AU655428B2 (OSRAM)
CA (1) CA2083957A1 (OSRAM)
FI (1) FI925545L (OSRAM)
HU (1) HUT64747A (OSRAM)
IL (1) IL98387A0 (OSRAM)
MA (1) MA22195A1 (OSRAM)
MX (1) MX26167A (OSRAM)
NZ (1) NZ238426A (OSRAM)
PL (1) PL290587A1 (OSRAM)
PT (1) PT97913A (OSRAM)
TW (1) TW221809B (OSRAM)
WO (1) WO1991018601A1 (OSRAM)
ZA (1) ZA914322B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006085A1 (en) * 1991-09-19 1993-04-01 Smithkline Beecham Corporation Pyridine compounds for treating leukotriene-related diseases
MA22926A1 (fr) * 1992-06-30 1994-04-01 Smithkline Beecham Corp Procede pour la preparation de nouveaux composes.
NZ254473A (en) 1992-06-30 1996-11-26 Smithkline Beecham Corp Preparation of phenylthiomethylpyridinylalkenoates
DE4224402A1 (de) * 1992-07-21 1994-01-27 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
GR1001409B (el) * 1992-10-15 1993-11-30 Smithkline Beecham Corp Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια.
ES2065234B1 (es) * 1992-10-27 1995-09-01 Smithkline Beecham Corp Compuestos para tratar enfermedades relacionadas con los leucotrienos.
US5643914A (en) * 1993-03-02 1997-07-01 Smithkline Beecham Corporation Pharmaceutical pyridine compounds
US5929096A (en) * 1996-02-29 1999-07-27 Smithkline Beecham Corporation Method for treating atopic dermatitis and contact dermatitis
JP2001501202A (ja) 1996-09-26 2001-01-30 ノバルティス アクチエンゲゼルシャフト ロイコトリエンb4(ltb―4)レセプターアンタゴニスト活性によるアリル置換アクリルアミド
PL2520654T3 (pl) 2003-08-26 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
EP3812363B1 (en) * 2018-06-22 2022-08-03 Panasonic Holdings Corporation Organic salt, hydroxy-radical sensor including same, and detection medium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056619A (en) * 1975-09-08 1977-11-01 Warner-Lambert Company 1-Substituted-2-(2-pyridinyl)ethanone N-oxides

Also Published As

Publication number Publication date
PT97913A (pt) 1992-03-31
TW221809B (OSRAM) 1994-03-21
CN1058015A (zh) 1992-01-22
FI925545A0 (fi) 1992-12-07
ZA914322B (en) 1992-06-24
AU8189691A (en) 1991-12-31
FI925545A7 (fi) 1992-12-07
JPH07116150B2 (ja) 1995-12-13
EP0593464A4 (en) 1993-02-12
HUT64747A (en) 1994-02-28
NZ238426A (en) 1994-11-25
AU655428B2 (en) 1994-12-22
JPH05507492A (ja) 1993-10-28
FI925545L (fi) 1992-12-07
EP0593464A1 (en) 1994-04-27
PL290587A1 (en) 1992-08-24
IL98387A0 (en) 1992-07-15
CA2083957A1 (en) 1991-12-08
MX26167A (es) 1994-02-28
HU9203867D0 (en) 1993-03-29
WO1991018601A1 (en) 1991-12-12
MA22195A1 (fr) 1992-04-01

Similar Documents

Publication Publication Date Title
KR920012040A (ko) 신규의 디히드로-이소퀴놀린 유도체
KR920009796A (ko) 3-아미도인돌릴 유도체
JP2005511592A5 (OSRAM)
CA2089767A1 (en) Pyridinyl thiadiazolyl- and oxadiazolyl derivatives
KR0139626B1 (ko) 강심제
RU2000131183A (ru) Производные оксииминоалкановой кислоты
KR880007411A (ko) 레티논산과 같은 작용을 갖는 에티닐헤테로 방향족-산류
KR900006318A (ko) 피페리디닐 벤즈이미다졸
KR960041168A (ko) 베타-아드레날린 효능성 작용물질
IE43916L (en) Allenic prostaglandins
CA2491612A1 (en) 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
KR900001683A (ko) 피페리딘 유도체
NO305515B1 (no) 5-amino-8-metyl-7-pyrrolidinylkinolin-3-karboksylsyrederivater og farmas°ytiske preparater inneholdende disse
KR900016135A (ko) 피부 및 점막-상피의 질환 치료용 4-퀴놀린 카복실산 유도체
UA42686C2 (uk) Похідні 3-хінуклідилових ефірів, проміжні сполуки та спосіб одержання 3-хінуклідилових ефірів, фармацевтична композиція, що має антимускаринову дію, та спосіб лікування хронічних обструктивних захворювань дихальних шляхів або астми
KR930700445A (ko) 로이코트리엔-관련 질병치료용 벤조산 유도체
US5739159A (en) Medicaments for the treatment of cardiac insufficiency
EP0470686A3 (en) (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma
JP2003509494A5 (OSRAM)
KR930700448A (ko) 로이코트리엔-관련 질병 치료용 아마이드 결합된 피리딜-벤조산 유도체
EP0649412B1 (en) Pharmaceutical pyridine compounds
KR960017669A (ko) 양쪽성 3환식 화합물
ATE120743T1 (de) Pyridoindolderivate und verfahren zu ihrer herstellung.
KR890012942A (ko) 5-치환된 오르니틴 유도체
KR960702438A (ko) 3-(인돌-3-일)프로페노산 유도체 및 N-메틸-D-아스파르테이트 길항제로서의 이의 용도[3-(lndol-3-yl)propenoic acid derivatives and as NMDA antagonists]

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19921204

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19960527

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19921204

Comment text: Patent Application

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19981014

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee